Newsletter Signup | Join Community
Perjeta improves outcomes in both early stage and advanced stage HER2-positive Breast Cancer
Short course radiation, brachytherapy & partial breast irradiation can be used to reduce side effects and inconvenience.
Enhertu precision cancer medicine approved for treatment of HER2-positive metastatic breast cancer.
Kadcyla precision cancer medicine improves survival in HER2-positive early stage and advanced breast cancer
Margetuximab improves progression-free survival compared to Herceptin® in patients with HER2+ metastatic breast cancer.
Kisqali prolongs survival and delays cancer progression for Pre-menopausal Hormone Receptor Positive Breast Cancer
Tucatinib in Locally Advanced or Metastatic HER2-Positive Breast Cancer: Update from San Antonio Breast Cancer Symposia.
Looking for women living with breast cancer for research study. The goal is to get your opinions…
I read where hormonal thearpy can cause cataracts; anyone had problems with this on Aromasin or…
Q. If you have breast implants do you need to get a mammogram?
Women with "dense" breasts require different screening for early detection-learn more here:…